HLS THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.65 CAD | -1.69% |
|
-6.06% | +17.72% |
| Apr. 08 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
| Mar. 14 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 5.260 | 5.260 | 6.860 |
| Spread/Res. | -11.60% | -11.60% | -32.22% |
| Spread/Supp. | +7.14% | +38.39% | +35.17% |
| Support | 4.340 | 3.360 | 3.440 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- HLS Stock
- Charts HLS Therapeutics Inc.
